Publication: Purinergic receptor expression and cellular responses to purinergic agonists in human prostate cancer cells
Issued Date
2017-01-01
Resource Type
ISSN
17917530
02507005
02507005
Other identifier(s)
2-s2.0-85012860533
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Anticancer Research. Vol.37, No.2 (2017), 529-538
Suggested Citation
Kornkamon Lertsuwan, Wachen Peters, Lindsay Johnson, Jomnarong Lertsuwan, Irene Marwa, Robert A. Sikes Purinergic receptor expression and cellular responses to purinergic agonists in human prostate cancer cells. Anticancer Research. Vol.37, No.2 (2017), 529-538. doi:10.21873/anticanres.11345 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/42060
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Purinergic receptor expression and cellular responses to purinergic agonists in human prostate cancer cells
Other Contributor(s)
Abstract
Background: Anticancer activity of extracellular nucleotides has been investigated in many types of cancer. Herein, the effects of extracellular nucleotides and the receptor profile for these nucleotides on prostate cancer (PCa) were elaborated. Materials and Methods: PCa cell lines representing different stages of PCa were used. The effects of ATP and adenosine on PCa growth and migration on different extracellular matrix proteins were examined by MTT and wound-healing assays. Purinergic receptor profiling was carried out by reverse transcription-polymerase chain reaction (RT-PCR). Results: A growth-inhibitory effect of ATP and adenosine was observed on all PCa cell lines tested. Several ATP-recognized P2 receptors and adenosine receptors were commonly expressed in PCa cell lines. Neither ATP nor adenosine had any significant effect on PCa migration. Conclusion: ATP and adenosine had an antiproliferative effect on PCa cells without affecting their motility, indicating their potential as a novel therapy for PCa.